Adverse Drug Reaction (ADRs): Clinical Identification, Assessment, and Reporting
ABSTRACT
Adverse drug reactions remain a critical challenge in modern healthcare, contributing to patient morbidity and hospital admissions. A systematic approach involving clinical identification, assessment, and reporting is essential for minimizing risks and improving therapeutic outcomes.
This article provides a structured overview of ADR classification, mechanism, clinical detection, and the role of pharmacovigilance system ensuring the safer and better use of medicine.
Background and clinical significance
Adverse Drug Reaction are defined by the National Institute of Health as harmful and unintended responses to a drug occurring at normal therapeutic doses. ADRs are recognized as a major global health concern, contributing significantly to morbidity and mortality.
The growing complexity of pharmacotherapy, polypharmacy, and variability in patient response detection and systematic evaluation of ADRs in clinical settings.
Studies demonstrate that ADRs are among the leading causes of hospital admissions and prolong hospital stays. impact on the patient health, Treatment costs cause economic burden additional diagnostic procedures, and loss of productivity.
CLASSIFICATION AND MECHANISM OF ADRs
Adverse drug reactions (ADRs) are broadly classified into Type A (Augmented) and Type B (Bizarre) reactions. Type A reactions are dose-dependent and predictable based on the pharmacological properties of the drug, whereas Type B reactions are unpredictable, not dose-dependent, and often serious in the nature.
Dose-Related Reaction (Toxic Effects):
These occur due to the increased drug concentration and are typically predictable. They may result from overdose, accumulating, or impaired drug metabolism.
Side Effects:
Pharmacological effects that occur at therapeutic doses are usually mild and manageable.
Drug-Drug Interactions:
Two or more medications reacts with each other can cause medications to stop working, becomes less effective, or produce harmful side effects. It is critical to consult pharmacists or doctors to manage risks.
Hypersensitivity Reaction:
Hypersensitivity reaction unknown or inappropriate immune response to antigens, causing tissue damage or dysfunction upon re-exposure.
Hypersensitivity reactions are unknown immune responses to antigens (allergens) categorized by the Gell and Coombs system into four main types-I-IV.
Idiosyncratic Reactions:
An Idiosyncratic reaction which is unpredictable, abnormal, and the one of the rare adverse drug reactions not related to dose or known pharmacological effects. often caused by genetic or metabolic differences.
- Severe rashes from medication like nevirapine
- Severe liver damage (hepatotoxicity) from halothane, or hemolytic anemia from primaquine in patients with G6DP deficiency.
Detection and Clinical Assessments of ADRs
The identification of ADRs requires careful clinical evaluation, and it ensures patient safety and optimizing therapeutic outcomes. Accurate identification requires a systematic and structured approach to evaluate the observed drug exposure and the observed adverse event.
Detection and clinical assessments:
Medication History:
Dechallenge (Drug withdrawal):
Exclusion of Alternative Causes:
Causality assessment is the systematic process of determining the likelihood that a specific drug is responsible for an observed adverse event. It is one of the most widely used applied tools.
Several standardized methods are used for the causality assessment, and Naranjo Scale
In pharmacovigilance from two coincidental events differentiate true adverse drug reactions.
Adverse drug reactions (ADRs) remain a significant concern in healthcare. A structured approach involving classification, clinical assessment, causality evaluation, and reporting is essential for effective management. Strengthening the pharmacovigilance practice can improve patient safety and ensure the safe use of medicines.

